Author:
Kai Knudsen
Updated:
4 June, 2026
Overview of clinically relevant drug interactions in anesthesia and intensive care – including anticoagulants, cardiovascular medications, neuromuscular blocking agents, electrolyte disturbances, and practical perioperative principles.
- Anesthesia-Specific Drug Interaction Summary
- Anticoagulants & Antiplatelets
- Warfarin + CYP Inhibitors (e.g., Metronidazole)
- Clopidogrel + Omeprazole
- Cardiovascular Drugs
- Digoxin + Verapamil
- Beta-blockers + Anesthetic Agents
- Neuromuscular Blockade Interactions
- Lithium + Neuromuscular Blockers
- Magnesium + Neuromuscular Blockers
- Antibiotics & CYP Interactions
- Clarithromycin + Statins
- Ciprofloxacin + Theophylline
- Metformin + IV Contrast / Hypoperfusion
- CNS-Active Drugs
- Isotretinoin + Tetracyclines
- Levodopa + Pyridoxine (without carbidopa)
- Electrolyte-Mediated Interactions
- ICU Amplifiers of Drug Interactions
- High-Yield “Red Flag” Combinations for Anesthesia
- Practical Anesthesia Principles
Anesthesia-Specific Drug Interaction Summary
In anesthesia, drug interactions become critical because:
- Hemodynamic reserve may be limited
- Ventilation is controlled
- Polypharmacy is common
- Renal and hepatic perfusion may be impaired
Below are the most clinically relevant interactions for anesthesiologists.
Clinical caution: Always verify dosing, contraindications, patient-specific factors, local guidelines and current official product information before applying this information in practice.
Anticoagulants & Antiplatelets
Warfarin + CYP Inhibitors (e.g., Metronidazole)
→ Increased INR → bleeding risk
Anesthetic relevance:
- Contraindication to neuraxial anesthesia if INR elevated
- Increased surgical bleeding
- Need for perioperative bridging strategy
Clopidogrel + Omeprazole
→ Reduced antiplatelet effect
Relevance:
- Increased risk of stent thrombosis
- Critical within 3–6 months post-PCI
- Preoperative medication reconciliation essential
Cardiovascular Drugs
Digoxin + Verapamil
→ Digoxin toxicity
Risk intraoperatively:
- Bradycardia
- AV block
- Hemodynamic instability
Practical approach:
- Continuous ECG monitoring
- Avoid adding other AV nodal blockers
Beta-blockers + Anesthetic Agents
→ Exaggerated hypotension and bradycardia
Risk:
- Blunted sympathetic response
- Reduced cardiac output
Key principle:
- Continue chronic beta-blockade
- Be prepared for vasopressor support
Neuromuscular Blockade Interactions
Lithium + Neuromuscular Blockers
→ Prolonged blockade
Mechanism:
Lithium interferes with neuromuscular transmission.
Clinical implication:
- Reduce dose of nondepolarizing agents
- Monitor with TOF
Magnesium + Neuromuscular Blockers
→ Potentiation of blockade
Common ICU scenario:
- Eclampsia treatment
- Hypomagnesemia correction
Risk:
- Prolonged paralysis
- Postoperative respiratory failure
Antibiotics & CYP Interactions
Clarithromycin + Statins
→ Rhabdomyolysis → AKI
ICU relevance:
- Hyperkalemia
- Arrhythmias
- Renal dysfunction affecting drug clearance
Ciprofloxacin + Theophylline
→ Seizures and arrhythmias
Anesthesia risk:
- Increased arrhythmogenic potential
- Increased CNS excitability
Metformin + IV Contrast / Hypoperfusion
→ Lactic acidosis
High-risk scenario:
- Sepsis
- Shock
- Major surgery
Practical:
- Hold metformin preoperatively in high-risk patients
- Monitor lactate
CNS-Active Drugs
Isotretinoin + Tetracyclines
→ Intracranial hypertension
Neuroanesthesia relevance:
- Elevated ICP
- Risk during intracranial procedures
Levodopa + Pyridoxine (without carbidopa)
→ Reduced levodopa efficacy
Perioperative issue:
- Parkinsonian rigidity
- Increased aspiration risk
Electrolyte-Mediated Interactions
Many drug interactions are amplified by electrolyte disturbances:
- Hypokalemia → Increased digoxin toxicity
- Hyperkalemia → Increased arrhythmia risk
- Hypomagnesemia → Torsades risk
- Hypocalcemia → Reduced myocardial contractility
Always interpret drug effects in context of electrolyte status.
ICU Amplifiers of Drug Interactions
- Renal failure → decreased drug clearance
- Hepatic dysfunction → altered metabolism
- Hypoalbuminemia → increased free drug fraction
- Hypothermia → altered pharmacokinetics
High-Yield “Red Flag” Combinations for Anesthesia
| Combination | Major Risk |
|---|---|
| Warfarin + CYP inhibitor | Bleeding |
| Lithium + NMB | Prolonged paralysis |
| Magnesium + NMB | Prolonged paralysis |
| Statin + Macrolide | Rhabdomyolysis |
| Metformin + Shock | Lactic acidosis |
| Digoxin + Verapamil | AV block |
Practical Anesthesia Principles
- Always review the medication list before induction.
- Anticipate altered drug sensitivity.
- Use neuromuscular monitoring when risk exists.
- Monitor ECG in high-risk interactions.
- Adjust doses in renal/hepatic dysfunction.
